Artia Global Partners LP Quant / Systematic

CIK: 0001937964 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 15, 2025

Total Value ($000): $395,095 (100.0% shares, 0.0% debt)

Holdings (35)

LLY ELI LILLY & CO 19.8%
Value ($000) $78,368 Shares 94,887 Est. Cost $826.69 Unrealized 0.0%
LLY ELI LILLY & CO 9.4%
Value ($000) $37,166 Shares 45,000 Est. Cost $826.69 Unrealized 0.0%
SLNO SOLENO THERAPEUTICS INC 9.0%
Value ($000) $35,616 Shares 498,473 Est. Cost $48.81 Unrealized -0.2%
VERONA PHARMA PLC 8.7%
Value ($000) $34,189 Shares 538,488 Est. Cost $48.37 Unrealized
INTRA-CELLULAR THERAPIES INC 7.3%
Value ($000) $28,985 Shares 219,719 Est. Cost $66.31 Unrealized
INSM INSMED INC 6.1%
Value ($000) $24,278 Shares 318,239 Est. Cost $66.59 Unrealized +14.9%
MERUS N V 4.5%
Value ($000) $17,873 Shares 424,640 Est. Cost $42.88 Unrealized
PTGX PROTAGONIST THERAPEUTICS INC 4.1%
Value ($000) $16,145 Shares 333,851 Est. Cost $36.55 Unrealized +14.6%
ACLX ARCELLX INC 3.8%
Value ($000) $15,028 Shares 229,085 Est. Cost $86.39 Unrealized -21.6%
AZN ASTRAZENECA PLC 3.5%
Value ($000) $14,020 Shares 190,752 Est. Cost $69.76 Unrealized
BSX BOSTON SCIENTIFIC CORP 3.3%
Value ($000) $13,084 Shares 129,700 Est. Cost $100.70 Unrealized 0.0%
SLNO SOLENO THERAPEUTICS INC 2.5%
Value ($000) $9,782 Shares 136,900 Est. Cost $48.81 Unrealized -0.2%
DGX QUEST DIAGNOSTICS INC 2.4%
Value ($000) $9,597 Shares 56,717 Est. Cost $161.93 Unrealized 0.0%
ALNY ALNYLAM PHARMACEUTICALS INC 2.0%
Value ($000) $7,723 Shares 28,600 Est. Cost $197.76 Unrealized +30.0%
SLNO SOLENO THERAPEUTICS INC 1.8%
Value ($000) $7,145 Shares 100,000 Est. Cost $48.81 Unrealized -0.2%
ARGX ARGENX SE 1.7%
Value ($000) $6,695 Shares 11,311 Est. Cost $387.47 Unrealized
NUVL NUVALENT INC 1.6%
Value ($000) $6,436 Shares 90,745 Est. Cost $92.60 Unrealized -15.6%
SRRK SCHOLAR ROCK HLDG CORP 1.4%
Value ($000) $5,536 Shares 172,185 Est. Cost $38.47 Unrealized 0.0%
RVMD REVOLUTION MEDICINES INC 0.9%
Value ($000) $3,684 Shares 104,190 Est. Cost $48.13 Unrealized -15.7%
RYTM RHYTHM PHARMACEUTICALS INC 0.7%
Value ($000) $2,649 Shares 50,000 Est. Cost $55.24 Unrealized +0.4%
SPRINGWORKS THERAPEUTICS INC 0.6%
Value ($000) $2,380 Shares 53,930 Est. Cost $49.22 Unrealized
VKTX VIKING THERAPEUTICS INC 0.6%
Value ($000) $2,180 Shares 90,279 Est. Cost $28.32 Unrealized +11.6%
VRDN VIRIDIAN THERAPEUTICS INC 0.5%
Value ($000) $2,157 Shares 160,000 Est. Cost $19.98 Unrealized -14.7%
TGTX TG THERAPEUTICS INC 0.5%
Value ($000) $2,150 Shares 54,515 Est. Cost $28.70 Unrealized +17.2%
ISRG INTUITIVE SURGICAL INC 0.4%
Value ($000) $1,733 Shares 3,500 Est. Cost $553.02 Unrealized 0.0%
EYPT EYEPOINT PHARMACEUTICALS INC 0.4%
Value ($000) $1,717 Shares 316,700 Est. Cost $9.59 Unrealized -27.0%
NBIX NEUROCRINE BIOSCIENCES INC 0.4%
Value ($000) $1,626 Shares 14,700 Est. Cost $117.13 Unrealized +8.2%
UTHR UNITED THERAPEUTICS CORP DEL 0.4%
Value ($000) $1,541 Shares 5,000 Est. Cost $342.70 Unrealized 0.0%
XENE XENON PHARMACEUTICALS INC 0.3%
Value ($000) $1,342 Shares 40,000 Est. Cost $46.00 Unrealized -17.5%
ASND ASCENDIS PHARMA A/S 0.3%
Value ($000) $1,160 Shares 7,440 Est. Cost $151.17 Unrealized
JANX JANUX THERAPEUTICS INC 0.3%
Value ($000) $1,029 Shares 38,100 Est. Cost $52.89 Unrealized -28.7%
MREO MEREO BIOPHARMA GROUP PLC 0.2%
Value ($000) $948 Shares 421,359 Est. Cost $3.30 Unrealized
TVTX TRAVERE THERAPEUTICS INC 0.1%
Value ($000) $554 Shares 30,900 Est. Cost $20.30 Unrealized 0.0%
CNTA CENTESSA PHARMACEUTICALS PLC 0.1%
Value ($000) $507 Shares 35,226 Est. Cost $15.99 Unrealized
ORKA ORUKA THERAPEUTICS INC 0.0%
Value ($000) $76 Shares 7,380 Est. Cost $12.47 Unrealized 0.0%